BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  Cardiovascular disease

  Lilly’s Tirzepatide Clears Phase III Cardiovascular Study on Heels of Novo

  Eli Lilly on Thursday released late-stage data showing a 38% reduction in the risk of heart failure outcomes, as it plays catch-up with Novo Nordisk’s semaglutide which won the FDA’s cardio nod in March.

  August 1, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  IRA

  Novo Loses IRA Case as NJ Judge Asserts Price Negotiations Are Voluntary

  Reiterating his ruling in a prior Inflation Reduction Act case, New Jersey District Court Judge Zahid Quraishi ruled that Novo Nordisk’s participation in the Medicare Drug Price Negotiation Program is of its own free will.

  August 1, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  UniDoc Launches Managed Services Offering

  August 1, 2024

   · 

  6 min read
• Press Releases

  DiamiR Biosciences Secures EU Patent Covering the Use of microRNA Biomarkers from Bodily Fluids for Differential Diagnosis of Amyotrophic Lateral Sclerosis

  August 1, 2024

   · 

  2 min read
• Press Releases

  COUR Pharmaceuticals Announces Leadership Transition for Strategic Growth Objectives

  August 1, 2024

   · 

  4 min read
• Press Releases

  Spectral Medical Provides July Tigris Trial Update

  August 1, 2024

   · 

  3 min read
• Press Releases

  RETRANSMISSION: Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports

  August 1, 2024

   · 

  9 min read
• Press Releases

  Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

  August 1, 2024

   · 

  4 min read
• Press Releases

  Lykos Therapeutics Announces New Initiatives and Measures for Additional Oversight for Midomafetamine-Assisted Therapy, if FDA Approved

  August 1, 2024

   · 

  13 min read
• Press Releases

  Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway

  August 1, 2024

   · 

  4 min read